{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:44:04Z","timestamp":1789609444708,"version":"build-2803163510"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The success of liver transplantation has increased over the past 20 years due to improved immunosuppressive medications, surgical technique and donor-recipient selection. To date, the number of patients waiting for a liver transplant exceeds the number of transplants performed yearly by over a 2\u200a:\u200a1 ratio. Despite efforts to expand the donor pool, mortality of patients waiting for a liver remains high due to the shortage of donor organs. Herein, we discuss options for liver replacement that are currently under development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Extracorporeal bioactive liver perfusion devices were investigated in the late 1990s and preliminarily demonstrated safety but failed to show clinical efficacy. Current research is ongoing, but the focus has shifted to xenotransplantation of whole organs, organ engineering and cell transplantation. These new modalities are limited to small and large animal studies and each present unique advantages and limitations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Discovery of new sources of organs or cells to replace a damaged liver may be the only long-term solution to provide definitive therapy to all patients who require transplantation. The past 2 years have seen notable achievements in xenotransplantation, tissue engineering and cell transplantation. Though challenges remain, now identified, they may be readily solved.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mot.0b013e3283534ec9","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T14:05:46Z","timestamp":1333461946000},"page":"235-240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Cellular therapy and bioartificial approaches to liver replacement"],"prefix":"10.1097","volume":"17","author":[{"given":"Jason A.","family":"Wertheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Soto-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20250502","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1600-6143.2011.03587.x","article-title":"Major challenges limiting liver transplantation in the United States.","volume":"11","author":"Wertheim","year":"2011","journal-title":"Am J Transplant"},{"key":"R3-6-20250502","first-page":"1446","article-title":"Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.","volume":"24","author":"Ellis","year":"1996","journal-title":"Hepatology"},{"key":"R4-6-20250502","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00201098","article-title":"Evolution and pathophysiology of the human natural antialpha-galactosyl IgG (anti-Gal) antibody.","volume":"15","author":"Galili","year":"1993","journal-title":"Springer Semin Immunopathol"},{"key":"R5-6-20250502","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1068228","article-title":"Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.","volume":"295","author":"Lai","year":"2002","journal-title":"Science"},{"key":"R6-6-20250502","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nbt0302-251","article-title":"Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs.","volume":"20","author":"Dai","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R7-6-20250502","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-6143.2009.02945.x","article-title":"Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: Clinical relevance.","volume":"10","author":"Ekser","year":"2010","journal-title":"Am J Transplant"},{"key":"R8-6-20250502","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/TP.0b013e3181e98d51","article-title":"Hepatic function after genetically engineered pig liver transplantation in baboons.","volume":"90","author":"Ekser","year":"2010","journal-title":"Transplantation"},{"key":"R9-6-20250502","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3727\/096368910X508898","article-title":"Human immune reactivity against liver sinusoidal endothelial cells from GALTalpha(1,3)GALT-deficient pigs.","volume":"19","author":"van Poll","year":"2010","journal-title":"Cell Transplant"},{"key":"R10-6-20250502","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/rmv.559","article-title":"Reappraisal of biosafety risks posed by PERVs in xenotransplantation.","volume":"18","author":"Louz","year":"2008","journal-title":"Rev Med Virol"},{"key":"R11-6-20250502","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.8493529","article-title":"Tissue engineering.","volume":"260","author":"Langer","year":"1993","journal-title":"Science"},{"key":"R12-6-20250502","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.2426782","article-title":"Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes.","volume":"233","author":"Demetriou","year":"1986","journal-title":"Science"},{"key":"R13-6-20250502","first-page":"3425","article-title":"Transplantation of hepatocytes using porous, biodegradable sponges.","volume":"26","author":"Mooney","year":"1994","journal-title":"Transplant Proc"},{"key":"R14-6-20250502","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C","article-title":"Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges.","volume":"37","author":"Mooney","year":"1997","journal-title":"J Biomed Mater Res"},{"key":"R15-6-20250502","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0041-1345(99)00208-0","article-title":"Long-term hepatocyte transplantation using three-dimensional matrices.","volume":"31","author":"Kaufmann","year":"1999","journal-title":"Transplant Proc"},{"key":"R16-6-20250502","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0041-1345(96)00169-8","article-title":"Enhanced survival of transgenic hepatocytes expressing hepatocyte growth factor in hepatocyte tissue engineering.","volume":"29","author":"Kim","year":"1997","journal-title":"Transplant Proc"},{"key":"R17-6-20250502","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3727\/000000001783986198","article-title":"The efficacy of prevascularization by basic fgf for hepatocyte transplantation using polymer devices in rats.","volume":"10","author":"Ogawa","year":"2001","journal-title":"Cell Transplant"},{"key":"R18-6-20250502","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/107632700320874","article-title":"Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system.","volume":"6","author":"Kim","year":"2000","journal-title":"Tissue Eng"},{"key":"R19-6-20250502","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/138920005774832632","article-title":"A microscale in vitro physiological model of the liver: Predictive screens for drug metabolism and enzyme induction.","volume":"6","author":"Sivaraman","year":"2005","journal-title":"Curr Drug Metab"},{"key":"R20-6-20250502","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/471661a","article-title":"Tissue models: a living system on a chip.","volume":"471","author":"Baker","year":"2011","journal-title":"Nature"},{"key":"R21-6-20250502","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development.","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R22-6-20250502","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1089\/ten.2006.0388","article-title":"Engineered liver-like tissue on a capillarized matrix for applied research.","volume":"13","author":"Linke","year":"2007","journal-title":"Tissue Eng"},{"key":"R23-6-20250502","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1576","article-title":"Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets.","volume":"13","author":"Ohashi","year":"2007","journal-title":"Nat Med"},{"key":"R24-6-20250502","first-page":"6529","article-title":"Whole organ decellularization: a tool for bioscaffold fabrication and organ bioengineering.","volume":"6526-","author":"Baptista","year":"2009","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"R25-6-20250502","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm.2170","article-title":"Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix.","volume":"16","author":"Uygun","year":"2010","journal-title":"Nat Med"},{"key":"R26-6-20250502","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nbt1257","article-title":"Reversal of mouse hepatic failure using an implanted liver-assist device containing es cell-derived hepatocytes.","volume":"24","author":"Soto-Gutierrez","year":"2006","journal-title":"Nat Biotechnol"},{"key":"R27-6-20250502","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.24067","article-title":"The use of whole organ decellularization for the generation of a vascularized liver organoid.","volume":"53","author":"Baptista","year":"2011","journal-title":"Hepatology"},{"key":"R28-6-20250502","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1089\/ten.2004.10.1046","article-title":"Assessing porcine liver-derived biomatrix for hepatic tissue engineering.","volume":"10","author":"Lin","year":"2004","journal-title":"Tissue Eng"},{"key":"R29-6-20250502","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: Using natures platform to engineer a bioartificial heart.","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"},{"key":"R30-6-20250502","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/ten.tec.2010.0698","article-title":"A whole-organ regenerative medicine approach for liver replacement.","volume":"17","author":"Soto-Gutierrez","year":"2011","journal-title":"Tissue Eng Part C Methods"},{"key":"R31-6-20250502","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.biomaterials.2010.01.120","article-title":"Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents in vitro.","volume":"31","author":"Bayrak","year":"2010","journal-title":"Biomaterials"},{"key":"R32-6-20250502","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.biomaterials.2008.01.005","article-title":"IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue.","volume":"29","author":"Bastian","year":"2008","journal-title":"Biomaterials"},{"key":"R33-6-20250502","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1083\/jcb.43.3.506","article-title":"High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study.","volume":"43","author":"Berry","year":"1969","journal-title":"J Cell Biol"},{"key":"R34-6-20250502","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2010.05.010","article-title":"Barriers to the successful treatment of liver disease by hepatocyte transplantation.","volume":"53","author":"Soltys","year":"2010","journal-title":"J Hepatol"},{"key":"R35-6-20250502","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrgastro.2010.44","article-title":"Human hepatocyte transplantation: Current experience and future challenges.","volume":"7","author":"Dhawan","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R37-6-20250502","doi-asserted-by":"crossref","first-page":"e18222","DOI":"10.1371\/journal.pone.0018222","article-title":"Isolation of primary human hepatocytes from normal and diseased liver tissue: A one hundred liver experience.","volume":"6","author":"Bhogal","year":"2011","journal-title":"PLoS One"},{"key":"R38-6-20250502","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOT.0b013e328337349d","article-title":"Ex-vivo normothermic liver perfusion: An update.","volume":"15","author":"Vogel","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"R39-6-20250502","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3727\/000000007783465000","article-title":"Cryopreservation-induced nonattachment of human hepatocytes: Role of adhesion molecules.","volume":"16","author":"Terry","year":"2007","journal-title":"Cell Transplant"},{"key":"R40-6-20250502","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/DMR-100100564","article-title":"Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.","volume":"32","author":"Hengstler","year":"2000","journal-title":"Drug Metab Rev"},{"key":"R41-6-20250502","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-3089.2011.00642.x","article-title":"Clinical pig liver xenotransplantation: How far do we have to go X","volume":"18","author":"Ekser","year":"2011","journal-title":"enotransplantation"},{"key":"R42-6-20250502","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.gastro.2006.10.013","article-title":"Prolonged survival of porcine hepatocytes in cynomolgus monkeys.","volume":"132","author":"Nagata","year":"2007","journal-title":"Gastroenterology"},{"key":"R43-6-20250502","first-page":"953","article-title":"Fetal liver cell transplantation as a potential alternative to whole liver transplantation J G","volume":"46","author":"Oertel","year":"2011","journal-title":"astroenterol"},{"key":"R44-6-20250502","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/dbio.2000.9912","article-title":"Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.","volume":"227","author":"Amit","year":"2000","journal-title":"Dev Biol"},{"key":"R45-6-20250502","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences.","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"R46-6-20250502","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors.","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"R47-6-20250502","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2008.10.047","article-title":"Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.","volume":"136","author":"Basma","year":"2009","journal-title":"Gastroenterology"},{"key":"R48-6-20250502","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"key":"R49-6-20250502","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.tp.0000231689.44266.ac","article-title":"Human hepatocyte transplantation: Worldwide results.","volume":"82","author":"Fisher","year":"2006","journal-title":"Transplantation"},{"key":"R50-6-20250502","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-60761-688-7_29","article-title":"Human hepatocyte transplantation.","volume":"640","author":"Dhawan","year":"2010","journal-title":"Methods Mol Biol"},{"key":"R51-6-20250502","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.TP.0000081560.16039.67","article-title":"Route of hepatocyte delivery affects hepatocyte engraftment in the spleen.","volume":"76","author":"Nagata","year":"2003","journal-title":"Transplantation"},{"key":"R52-6-20250502","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the crigler-najjar syndrome type i with hepatocyte transplantation.","volume":"338","author":"Fox","year":"1998","journal-title":"N Engl J Med"},{"key":"R53-6-20250502","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.22573","article-title":"Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation.","volume":"49","author":"Yamanouchi","year":"2009","journal-title":"Hepatology"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201206000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:05:20Z","timestamp":1746223520000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201206000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283534ec9","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}